Neoadjuvant chemotherapy (NC) should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer (MIUC) of the bladder – A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process

Authors

  • Jo-An Seah Princess Margaret Hospital
  • Srikala Sridhar Princess Margaret Hospital
  • Lori Wood QEII Health Sciences Centre, NS
  • Normand Blais CHUM - Hôpital Notre-Dame
  • Scott North Cross Cancer Institute
  • Yasmin Rahim Stronach Regional Cancer Centre
  • Dean Ruether University of Calgary
  • Peter Black UBC
  • Alexandre R. Zlotta

DOI:

https://doi.org/10.5489/cuaj.1506

Abstract

Neoadjuvant chemotherapy (NC) improves overall survival inpatients with resectable muscle-invasive urothelial cancer of the bladder (MIBC). However uptake of NC in Canada is disappointingly low. Following a detailed literature review and in consultation with urologic oncology, the Canadian Association of Genitourinary Medical Oncologists (CAGMO) has developed a consensus statement for the use of NC in MIBC. Our primary goal is to increase the uptake of NC for MIBC in Canada and improve patient outcomes.

Downloads

Download data is not yet available.

Downloads

Published

2013-10-09

How to Cite

Seah, J.-A., Sridhar, S., Wood, L., Blais, N., North, S., Rahim, Y., Ruether, D., Black, P., & Zlotta, A. R. (2013). Neoadjuvant chemotherapy (NC) should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer (MIUC) of the bladder – A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process. Canadian Urological Association Journal, 7(9-10), 312–8. https://doi.org/10.5489/cuaj.1506

Issue

Vol. 7 No. 9-10 (2013): CUAJ October

Section

Consensus Statement

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.